Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19

BACKGROUND: Hydroxychloroquine (HC) ± azithromycin (AZ) is widely used for Covid-19. The Qatar Prospective RCT of Expediting Coronavirus Tapering (Q-PROTECT) aimed to assess virologic cure rates of HC±AZ in cases of low-acuity Covid-19. METHODS: Q-PROTECT employed a prospective, placebo-controlled d...

Descripción completa

Detalles Bibliográficos
Autores principales: Omrani, Ali S., Pathan, Sameer A., Thomas, Sarah A., Harris, Tim R.E., Coyle, Peter V., Thomas, Caroline E., Qureshi, Isma, Bhutta, Zain A., Mawlawi, Naema Al, Kahlout, Reham Al, Elmalik, Ashraf, Azad, Aftab M., Daghfal, Joanne, Mustafa, Mulham, Jeremijenko, Andrew, Soub, Hussam Al, Khattab, Mohammed Abu, Maslamani, Muna Al, Thomas, Stephen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678437/
https://www.ncbi.nlm.nih.gov/pubmed/33251500
http://dx.doi.org/10.1016/j.eclinm.2020.100645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678437/
https://www.ncbi.nlm.nih.gov/pubmed/33251500
http://dx.doi.org/10.1016/j.eclinm.2020.100645

Ejemplares similares